Sandbox: Leukocytosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 13: | Line 13: | ||
==Classification== | ==Classification== | ||
*Leukocytosis may be classified | *Leukocytosis may be classified into 5 subtypes: | ||
:*[[Neutrophilia]] (most common) | :*[[Neutrophilia]] (most common) | ||
:*[[Lymphocytosis]] | :*[[Lymphocytosis]] | ||
| Line 20: | Line 20: | ||
:*[[Basophilia]]. | :*[[Basophilia]]. | ||
*Leukocytosis may be classified | *Leukocytosis may also be classified into 2 groups: | ||
:*Left shift (most common) | :*'''Left shift''' (most common) | ||
:*Right shift | ::*Immature leukocytes increase | ||
::*Proliferation and release of granulocyte and monocyte precursors in the bone marrow | |||
::*Usually stimulated by several products of inflammation including C3a and G-CSF | |||
:*'''Right shift''' | |||
::*Reduced count or lack of "young neutrophils" | |||
::*Associated with the presence of "giant neutrophils | |||
==Pathophysiology== | ==Pathophysiology== | ||
Revision as of 16:30, 23 May 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Synonyms and keywords:
Overview
Leukocytosis is an elevation of the white blood cell count above the normal range. Leukocytosis is frequently a sign of an inflammatory response, most commonly the result of infection, but may also occur following certain parasitic infections, bone tumors, strenuous exercise, emotional stress, pregnancy, anesthesia, and epinephrine administration. Leukocytosis may be classified into 5 subtypes: neutrophilia (most common), lymphocytosis, monocytosis, eosinophilia, and basophilia. Other classification, include:Left shift or right shift leucocytosis. The pathogenesis of leukocytosis is characterized by the increase of leukocytes (primarily neutrophils), followed by the proliferation and release of granulocyte and monocyte precursors in the bone marrow which is stimulated by several products of inflammation including C3a and G-CSF.
Historical Perspective
- Leukocytosis was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
Classification
- Leukocytosis may be classified into 5 subtypes:
- Neutrophilia (most common)
- Lymphocytosis
- Monocytosis
- Eosinophilia
- Basophilia.
- Leukocytosis may also be classified into 2 groups:
- Left shift (most common)
- Immature leukocytes increase
- Proliferation and release of granulocyte and monocyte precursors in the bone marrow
- Usually stimulated by several products of inflammation including C3a and G-CSF
- Right shift
- Reduced count or lack of "young neutrophils"
- Associated with the presence of "giant neutrophils
Pathophysiology
- The pathogenesis of leukocytosis is characterized by [feature1], [feature2], and [feature3].
- The [gene name] gene/Mutation in [gene name] has been associated with the development of leukocytosis, involving the [molecular pathway] pathway.
- On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of leukocytosis.
Causes
- To see causes of leukocytosis, please click here
Epidemiology and Demographics
- The prevalence of leukocytosis is approximately [number or range] per 100,000 individuals worldwide.
- In [year], the incidence of leukocytosis was estimated to be [number or range] cases per 100,000 individuals in [location].
Age
- Patients of all age groups may develop leukocytosis.
- Leukocytosis is more commonly observed among patients aged [age range] years old.
- Leukocytosis is more commonly observed among [elderly patients/young patients/children].
Gender
- Leukocytosis affects men and women equally.
- [Gender 1] are more commonly affected with leukocytosis than [gender 2].
- The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
Race
- There is no racial predilection for leukocytosis.
- Leukocytosis usually affects individuals of the [race 1] race.
- [Race 2] individuals are less likely to develop leukocytosis.
Risk Factors
- Common risk factors in the development of leukocytosis, include:
Natural History, Complications and Prognosis
- The majority of patients with leukocytosis remain asymptomatic for [duration/years].
- Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
- If left untreated, [#%] of patients with leukocytosis may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
- Common complications of leukocytosis include [complication 1], [complication 2], and [complication 3].
- Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with leukocytosis is approximately [#%].
Diagnosis
Symptoms
- Leukocytosis is usually asymptomatic.
- Symptoms of leukocytosis may include the following:
- [symptom 1]
- [symptom 2]
- [symptom 3]
- [symptom 4]
- [symptom 5]
- [symptom 6]
Laboratory Findings
- Laboratory findings consistent with the diagnosis of leukocytosis include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
Other Diagnostic Studies
- Leukocytosis may also be diagnosed using [diagnostic study name].
- Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].
Treatment
Medical Therapy
- There is no treatment for leukocytosis; the mainstay of therapy is supportive care.
- The mainstay of therapy for leukocytosis is [medical therapy 1] and [medical therapy 2].
- [Medical therapy 1] acts by [mechanism of action1].
- Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].